Environmental & Healthcare Legislative Watch50 States · D.C. · U.S. Congress
From official state and federal legislative records. Informational only, not legal advice.
Just proposed
A lawmaker wrote this idea down and officially asked the government to consider it.
Next: a committee studies it and decides if it moves forward.
In plain words
AI summaryWritten by AI from the bill text. Check the official text before relying on it.
Chimeric antigen receptor T-cell therapy. Provides that a policy of accident and sickness insurance or health maintenance organization contract that provides coverage for chimeric antigen receptor (CAR) T-cell therapy may not refuse to contract or deny coverage for the administration of any CAR T-cell therapy by any provider that qualifies as a certified health care facility by the federal Food and Drug Administration for the applicable CAR T-cell therapy.
